Prostate Cancer Resources

home  » cancer resources »  prostate cancer

Prostate Cancer Treatment Research & Sources of Support

Kenneth S. Pope, Ph.D., ABPP

 

I gathered the resources on this page to help men with prostate cancer and their loved ones to find information, support, and other resources. These resources are meant to complement and not replace any advice or information from a health care professional.

I created this site to be fully accessible for people with disabilities; please follow this link to change text size, color, or contrast; please follow this link for other accessibility functions for those with visual, mobility, and other disabilities.

There are 4 sections of resources:

1) 4 Books for Getting Started

2) 51 Recent (i.e., published in 2016) research articles on prostate cancer treatments

3) 47 Recent article on psychological aspects of prostate cancer

4) 22 Links to web sites providing information and support

PLEASE NOTE: This web site includes 8 other pages of related sets of resources:

Prostate Cancer Resources:


BOOKS

Four of the best books for getting started are:

1. Johns Hopkins Medicine. (2010). Choosing the right treatment for prostate cancer. New York: Remedy Health Media. This brief, to-the-point 97-page guide, which can be purchased and downloaded in pdf format, discusses the strengths and weaknesses of the various methods of treating prostate cancer. What many readers may find particularly useful are disclosures of information about each method that may not appear in all the guides (e.g., controversies over how insurance coverage issues may influence the amount of radiation given per dose in some methods of radiation therapy).

2. Mydlo, J. H. & Godec, C.J. (Editors). (2015). Prostate Cancer: Science and Clinical Practice, 2nd Edition. This 602-page comprehensive review is edited Mydio, who is Professor and Chair of Urology at Temple University School of Medicine, and Godec, who was previously Chair of Urology at Long Island College Hospital and is currently Urology Residency Director and Associate Chief of the Division of Urology at Maimonides Medical Center.

3. Torrey, E. F. (2006). Surviving prostate cancer: What you need to know to make informed decisions. New Haven: Yale University Press. A warm, humane, frank, engaging, and richly informative 280-page guide by "a research psychiatrist and associate director for laboratory research at the Stanley Medical Research Institute," who himself had prostate cancer. It's very readable and includes illuminating, sometimes surprising quotes from men (e.g., Anatole Broyard, General Norman Schwarzkopf, Michael Korda) about their own prostate cancer.

4. Walsh, P. C., & Worthington, J. F. (2013). Dr. Walsh's guide to surviving prostate cancer (3rd ed.). New York: Warner Wellness. This exceptionally detailed and informative 592-page book was co-authored by the Distinguished Service Professor of Urology at the Brady Urological Institute of the Johns Hopkins (Walsh) and an award-winning science writer (Worthington).

Because books can become dated in their coverage of the latest research, I've included below a list of recent (i.e., published in 2010-2014) research articles on the various treatment approaches (e.g., watchful waiting, surgery, brachytherapy, external beam radiation, androgen deprivation therapy).

I've also included a list of recent (i.e., published in 2011-2016) articles on psychological aspects of prostate cancer (e.g., stress management, anxiety, depression, PTSD, psychosocial & behavioral interventions).

At the end below are links to web sites that may be useful in finding information, guidance, and support.

 

47 RECENT ARTICLES (I.E., PUBLISHED IN 2011-2016) ON PSYCHOLOGICAL ASPECTS OF PROSTATE CANCER (E.G., STRESS MANAGEMENT, QUALITY OF LIFE, ANXIETY, DEPRESSION, PTSD, PSYCHOSOCIAL & BEHAVIORAL INTERVENTIONS):

Anastasiou, I., Yiannopoulou, K. G., Mihalakis, A., Hatziandonakis, N., Constantinides, C., Papageorgiou, C., et al. (2011). Symptoms of acute posttraumatic stress disorder in prostate cancer patients following radical prostatectomy. American journal of men's health, 5(1), 84-89.

Arrington, M. I. (2015). Uncertainty and stigma in the experiences of prostate cancer survivors: A thematic analysis of narrative elements. Illness, Crisis, & Loss, 23(3), 242-260. doi: 10.1177/1054137315585684

Badger, T. A., Segrin, C., Figueredo, A. J., Harrington, J., Sheppard, K., Passalacqua, S., & Bishop, M. (2011). Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners.Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 20(6), 833-844.

Bancroft, E. K., Castro, E., Bancroft, G. A., Ardern-Jones, A., Moynihan, C., Page, E., et al. (2015). The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer. Psycho-Oncology, published online prior to print publication.

Benedict, C., Dahn, J. R., Antoni, M. H., Traeger, L., Kava, B., Bustillo, N., et al. (2015). Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: Considering the role of social support and stress. Psycho-Oncology, 24(8), 932-939. doi: 10.1002/pon.3681

Bustillo, N. E., McGinty, H. L., Dahn, J. R., Yanez, B., Antoni, M. H., Kava, B. R., et al. (2015). Fatalism, medical mistrust, and pretreatment health-related quality of life in ethnically diverse prostate cancer patients. Psycho-Oncology, published online prior to print publication.

Chambers, S. K., Pinnock, C., Lepore, S. J., Hughes, S., & O'Connell, D. L. (2011). A systematic review of psychosocial interventions for men with prostate cancer and their partners.Patient Education and Counseling, 85(2), e75-e88.

Chien, C.-H., Liu, K.-L., Chien, H.-T., & Liu, H.-E. (2014). The effects of psychosocial strategies on anxiety and depression of patients diagnosed with prostate cancer: A systematic review. International Journal of Nursing Studies, 51(1), 28-38.

Chipperfield, K., Fletcher, J., Millar, J., Brooker, J., Smith, R., Frydenberg, M., & Burney, S. (2013). Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy. Psychooncology. doi: 10.1002/pon.3269

Christie, D. R. H., Sharpley, C. F., & Bitsika, V. (2015). Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. Psycho-Oncology, 24(9), 1002-1011. doi: 10.1002/pon.3776

Cohen, L., Parker, P. A., Vence, L., Savary, C., Kentor, D., Pettaway, C., et al. (2011). Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosomatic medicine, 73(3), 218-225.

Collins, A. L., Love, A. W., Bloch, S., Street, A. F., Duchesne, G. M., Dunai, J., & Couper, J. W. (2013). Cognitive Existential Couple Therapy for newly diagnosed prostate cancer patients and their partners: a descriptive pilot study. Psychooncology, 22(2), 465-469.

Costanza, M. E., Luckmann, R. S., Rosal, M., White, M. J., LaPelle, N., Partin, M., et al. (2011). Helping men make an informed decision about prostate cancer screening: A pilot study of telephone counseling. Patient Education and Counseling, 82(2), 193-200.

De Sousa, A., Sonavane, S., & Mehta, J. (2012). Psychological aspects of prostate cancer: a clinical review. Prostate Cancer Prostatic Dis. doi: 10.1038/pcan.2011.66

Ezer, H. l. n., Chachamovich, J. L. R., & Chachamovich, E. (2011). Do men and their wives see it the same way? Congruence within couples during the first year of prostate cancer. Psycho-oncology, 20(2), 155-164.

Galvão, D. A., Newton, R. U., Gardiner, R. A., Girgis, A., Lepore, S. J., Stiller, A., et al. (2015). Compliance to exercise-oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life. Psycho-Oncology, 24(10), 1241-1249. doi: 10.1002/pon.3882

Gerhart, J., Asvat, Y., Lattie, E., O'Mahony, S., Duberstein, P., & Hoerger, M. (2015). Distress, delay of gratification and preference for palliative care in men with prostate cancer. Psycho-Oncology, published online prior to print publication.

Gilbert, S. M., Dunn, R. L., Wittmann, D., Montgomery, J. S., Hollingsworth, J. M., Miller, D. C., et al. (2015). Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic. Cancer, 121(9), 1484-1491. doi: 10.1002/cncr.29215

Greeff, A., & Thiel, C. (2012). Resilience in families of husbands with prostate cancer.Educational Gerontology, 38(3), 179-189.

Green, H. J., Wells, D. J. N., & Laakso, L. (2011). Coping in men with prostate cancer and their partners: A quantitative and qualitative study. European journal of cancer care, 20(2), 237-247.

Hamilton, L. D., Van Dam, D., & Wassersug, R. J. (2015). The perspective of prostate cancer patients and patients' partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples. Psycho-Oncolog, published online prior to print publication.

Hervouet, S., Savard, J., Ivers, H., & Savard, M. H. (2013). Depression and Androgen Deprivation Therapy for Prostate Cancer: A Prospective Controlled Study. Health Psychol. doi: 10.1037/a0031639

Kamen, C., Mustian, K. M., Heckler, C., Janelsins, M. C., Peppone, L. J., Mohile, S., et al. (2015). The association between partner support and psychological distress among prostate cancer survivors in a nationwide study. Journal of Cancer Survivorship, 9(3), 492-499. doi: 10.1007/s11764-015-0425-3

Kazer, M. W., Harden, J., Burke, M., Sanda, M. G., Hardy, J., & Bailey, D. E. (2011). The experiences of unpartnered men with prostate cancer: A qualitative analysis.Journal of Cancer Survivorship, 5(2), 132-141

Lamers, R. E. D., Cuypers, M., Husson, O., Vries, M., Kil, P. J. M., Ruud Bosch, J. L. H., et al. (2015). Patients are dissatisfied with information provision: Perceived information provision and quality of life in prostate cancer patients. Psycho-Oncology, published online prior to print publication.

Lee, M., Jim, H. S., Fishman, M., Zachariah, B., Heysek, R., Biagioli, M., et al. (2015). Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: A controlled comparison. Psycho-Oncology, 24(4), 472-477. doi: 10.1002/pon.3608

Lehto, U.-S., Helander, S., Taari, K., & Aromaa, A. (2015). Patient experiences at diagnosis and psychological well-being in prostate cancer: A Finnish national survey. European Journal of Oncology Nursing, 19(3), 220-229.

Manne, S. L., Kissane, D., Zaider, T., Kashy, D., Lee, D., Heckman, C., et al. (2015). Holding back, intimacy, and psychological and relationship outcomes among couples coping with prostate cancer. Journal of Family Psychology, 29(5), 708-719. doi: 10.1037/fam0000096

McGowan, E. L., North, S., & Courneya, K. S. (2013). Randomized controlled trial of a behavior change intervention to increase physical activity and quality of life in prostate cancer survivors. Annals of Behavioral Medicine, 46(3), 382-393.

Mollica, M. A., Underwood Iii, W., Homish, G. G., Homish, D. L., & Orom, H. (2016). Spirituality is associated with better prostate cancer treatment decision making experiences. Journal of Behavioral Medicine, 39(1), 161-169. doi: 10.1007/s10865-015-9662-1

Nanton, V., & Dale, J. (2011). 'It don't make sense to worry too much': the experience of prostate cancer in African-Caribbean men in the UK. European journal of cancer care, 20(1), 62-71.

Nelson, C. J., Mulhall, J. P., & Roth, A. J. (2011). The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer. Journal of Sexual Medicine, 8(2), 560-566.

Paterson, C., Robertson, A., Smith, A., & Nabi, G. (2015). Identifying the unmet supportive care needs of men living with and beyond prostate cancer: A systematic review. European Journal of Oncology Nursing, 19(4), 405-418. doi: 10.1016/j.ejon.2014.12.007

Rivers, B. M., August, E. M., Gwede, C. K., Hart, A., Jr., Donovan, K. A., Pow-Sang, J. M., et al. (2011). Psycho-social issues related to sexual functioning among African-American prostate cancer survivors and their spouses. Psycho-oncology, 20(1), 106-110.

Ross, K. M., Ranby, K. W., Wooldridge, J. S., Robertson, C., & Lipkus, I. M. (2015). Effects of physical and mental health on relationship satisfaction: A dyadic, longitudinal examination of couples facing prostate cancer. Psycho-Oncology, published online prior to print publication.

Saini, A., Berruti, A., Cracco, C., Sguazzotti, E., Porpiglia, F., Russo, L., & Ostacoli, L. (2013). Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. Urol Oncol, 31(3), 352-358.

Segrin, C., Badger, T. A., & Figueredo, A. J. (2011). Stage of disease progression moderates the association between social support and depression in prostate cancer survivors.Journal of Psychosocial Oncology, 29(5), 552-560. 

Segrin, C., Badger, T. A., & Harrington, J. (2012). Interdependent psychological quality of life in dyads adjusting to prostate cancer.Health Psychology, 31(1), 70-79

Sharp, L., O'Leary, E., Kinnear, H., Gavin, A., & Drummond, F. J. (2015). Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: Results from the picture study. Psycho-Oncology, published online prior to print publication.

Sharpley, C. F., Bitsika, V., & Christie, D. R. H. (2013). The incidence and causes of different subtypes of depression in prostate cancer patients: Implications for cancer care. European Journal of Cancer Care, 22(6), 815-823.

Sharpley, C. F., Bitsika, V., & Christie, D. R. H. (2015). The relative influence of patients' self-reported depressive symptoms of cognitive deficit and cognitive bias on total depression in prostate cancer patients: Implications for psychotherapy interventions. Asia Pacific Journal of Counselling and Psychotherapy, 6(1-2), 70-79. doi: 10.1080/21507686.2014.1002802

Sharpley, C. F., Christie, D. R. H., Bitsika, V., & Miller, B. J. (2016). Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy. Psycho-Oncology, published online prior to print publication.

Song, L., Northouse, L. L., Zhang, L., Braun, T. M., Cimprich, B., Ronis, D. L., & Mood, D. W. (2012). Study of dyadic communication in couples managing prostate cancer: A longitudinal perspective.Psycho-Oncology, 21(1), 72-81. 

Torbit, L. A., Albiani, J. J., Crangle, C. J., Latini, D. M., & Hart, T. L. (2015). Fear of recurrence: The importance of self-efficacy and satisfaction with care in gay men with prostate cancer. Psycho-Oncology, 24(6), 691-698.

van Tol-Geerdink, J. J., Leer, J. W. H., Wijburg, C. J., Oort, I. M., Vergunst, H., Lin, E. J., et al. (2016). Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial. Health Expectations: An International Journal of Public Participation in Health Care & Health Policy, 19(2), 459-470. doi: 10.1111/hex.12369

van Tol-Geerdink, J. J., Leer, J. W., van Lin, E. N., Schimmel, E. C., & Stalmeier, P. F. (2011). Depression related to (neo)adjuvant hormonal therapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 98(2), 203-206.

Wiechno, P. J., Sadowska, M., Kalinowski, T., Michalski, W., & Demkow, T. (2013). Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life? Psychooncology, 22(2), 346-351.

51 RECENT (I.E., PUBLISHED IN 2016) RESEARCH ARTICLES ON TREATMENT APPROACHES (E.G., WATCHFUL WAITING, SURGERY, BRACHYTHERAPY, EXTERNAL BEAM RADITION, ANDROGEN DEPRIVATION THERAPY)

  1. Almeida, G. L., Petralia, G., Ferro, M., Ribas, C. A., Detti, S., Jereczek-Fossa, B. A., et al. (2016). Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria. Urol Int. doi: 10.1159/000444197

    Arcangeli, S., Zilli, T., De Bari, B., & Alongi, F. (2016). "Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? Crit Rev Oncol Hematol, 97, 231-237. doi: 10.1016/j.critrevonc.2015.08.023

    Armstrong, A. J., Halabi, S., Healy, P., Lee, W. R., Koontz, B. F., Moul, J. W., et al. (2016). A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy. Prostate Cancer Prostatic Dis, 19(1), 100-106. doi: 10.1038/pcan.2015.59

    Barbosa, P. V., Thomas, I. C., Srinivas, S., Buyyounouski, M. K., Chung, B. I., Chertow, G. M., et al. (2016). Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable? Eur Urol. doi: 10.1016/j.eururo.2016.02.037

    Barzi, A., Klein, E. A., Dorff, T. B., Quinn, D. I., & Sadeghi, S. (2016). Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer. Prostate Cancer Prostatic Dis, 19(1), 84-91. doi: 10.1038/pcan.2015.56

    Bellavita, R., Scricciolo, M., Bini, V., Arcidiacono, F., Montesi, G., Lancellotta, V., et al. (2016). Radiotherapy for early-stage prostate cancer in men under 70 years of age. Tumori, 102(2), 209-216. doi: 10.5301/tj.5000433

    Bryant, C., Smith, T. L., Henderson, R. H., Hoppe, B. S., Mendenhall, W. M., Nichols, R. C., et al. (2016). Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys, 95(1), 422-434. doi: 10.1016/j.ijrobp.2016.02.038

    Cattarino, S., Salciccia, S., Gentilucci, A., Innocenzi, M., Gentile, V., & Sciarra, A. (2016). Intermittent androgen deprivation in prostate cancer cases with biochemical progression after radical prostatectomy: Are we ready to treat? Crit Rev Oncol Hematol, 99, 351-361. doi: 10.1016/j.critrevonc.2016.01.008

    Chen, Y. W., Mahal, B. A., Muralidhar, V., Nezolosky, M., Beard, C. J., Den, R. B., et al. (2016). Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys, 94(4), 683-690. doi: 10.1016/j.ijrobp.2015.12.008

    Chong, R. W., Vasudevan, V., Zuber, J., & Solomon, S. S. (2016). Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus. Am J Med Sci, 351(4), 416-419. doi: 10.1016/j.amjms.2016.01.013

    Crehange, G., Izaguirre, A., Weinberg, V., Hsu, C. C., Gottschalk, A. R., Hsu, I. C., et al. (2016). Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol, 39(2), 167-172. doi: 10.1097/COC.0000000000000032

    Daniels, C. P., Millar, J. L., Spelman, T., Sengupta, S., & Evans, S. M. (2016). Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry. J Med Imaging Radiat Oncol, 60(2), 247-254. doi: 10.1111/1754-9485.12407

    Das, D., Persaud, L., Dejoie, J., Happy, M., Brannigan, O., De Jesus, D., et al. (2016). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) activates caspases in human prostate cancer cells through sigma 1 receptor. Biochem Biophys Res Commun, 470(2), 319-323. doi: 10.1016/j.bbrc.2016.01.055

    Daskivich, T. J., Lai, J., Dick, A. W., Setodji, C. M., Hanley, J. M., Litwin, M. S., et al. (2016). Questioning the Ten-Year Life Expectancy Rule for High-Grade Prostate Cancer: Comparative Effectiveness of Aggressive Vs. Non-Aggressive Treatment of High-Grade Disease in Older Men with Differing Comorbid Disease Burdens. Urology. doi: 10.1016/j.urology.2016.02.057

    DellOglio, P., Karnes, R. J., Joniau, S., Spahn, M., Gontero, P., Tosco, L., et al. (2016). Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer. Urol Oncol, 34(5), 234 e213-234 e219. doi: 10.1016/j.urolonc.2015.11.018

    Di Muzio, N. G., Fodor, A., Noris Chiorda, B., Broggi, S., Mangili, P., Valdagni, R., et al. (2016). Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study. Clin Oncol (R Coll Radiol). doi: 10.1016/j.clon.2016.02.005

    Dickinson, L., Arya, M., Afzal, N., Cathcart, P., Charman, S. C., Cornaby, A., et al. (2016). Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort. Eur Urol. doi: 10.1016/j.eururo.2016.02.054

    Fodor, A., Berardi, G., Fiorino, C., Picchio, M., Busnardo, E., Kirienko, M., et al. (2016). Toxicity and efficacy of salvage 11C-Choline PET/CT-guided radiation therapy in patients with prostate cancer lymph nodal recurrence. BJU Int. doi: 10.1111/bju.13510

    Fossati, N., Passoni, N. M., Moschini, M., Gandaglia, G., Larcher, A., Freschi, M., et al. (2016). Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades. BJU Int, 117(5), 740-747. doi: 10.1111/bju.13125

    Goris Gbenou, M. C., Peltier, A., Schulman, C. C., & Velthoven, R. V. (2016). Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy. Urol Oncol. doi: 10.1016/j.urolonc.2015.12.009

    Habl, G., Uhl, M., Katayama, S., Kessel, K. A., Hatiboglu, G., Hadaschik, B., et al. (2016). Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study-The IPI Trial. Int J Radiat Oncol Biol Phys, 95(1), 435-443. doi: 10.1016/j.ijrobp.2016.02.025

    Hamdy, F. C., et al. (2016) 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. New England Journal of Medicine, published online in advance of print publication.

    Herlemann, A., Wenter, V., Kretschmer, A., Thierfelder, K. M., Bartenstein, P., Faber, C., et al. (2016). Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer. Eur Urol. doi: 10.1016/j.eururo.2015.12.051

    Holtzman, A. L., Hoppe, B. S., Letter, H. P., Bryant, C., Nichols, R. C., Henderson, R. H., et al. (2016). Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound. Int J Radiat Oncol Biol Phys, 95(1), 465-471. doi: 10.1016/j.ijrobp.2015.12.351

    Hoyne, G., Rudnicka, C., Sang, Q. X., Roycik, M., Howarth, S., Leedman, P., et al. (2016). Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer. BMC Cancer, 16(1), 151. doi: 10.1186/s12885-016-2178-4

    James, N. D., Pirrie, S. J., Pope, A. M., Barton, D., Andronis, L., Goranitis, I., et al. (2016). Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial. JAMA Oncol, 2(4), 493-499. doi: 10.1001/jamaoncol.2015.5570

    Lavan, N. A., Kavanagh, D. O., Martin, J., Small, C., Joyce, M. R., Faul, C. M., et al. (2016). The curative management of synchronous rectal and prostate cancer. Br J Radiol, 89(1057), 20150292. doi: 10.1259/bjr.20150292

    Lazar, A. A., Lizarraga, T. L., & Roach, M., 3rd. (2016). Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010: Radical Prostatectomy Versus Radiation for Clinically Localized Prostate Cancer: Two Systematic Reviews and a Randomized Controlled Trial. Eur Urol. doi: 10.1016/j.eururo.2016.02.042

    Lou, D. Y., & Fong, L. (2016). Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor. Urol Oncol, 34(4), 182-192. doi: 10.1016/j.urolonc.2013.12.001

    Mandel, P., Steuber, T., Ahyai, S., Kriegmair, M., Schiffmann, J., Boehm, K., et al. (2016). Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria. BJU Int, 117(1), 55-61. doi: 10.1111/bju.13103

    Minana, B., Rodriguez-Antolin, A., Gomez-Veiga, F., Hernandez, C., Suarez, J. F., Fernandez-Gomez, J. M., et al. (2016). Treatment trends for clinically localised prostate cancer. National population analysis: GESCAP group. Actas Urol Esp, 40(4), 209-216. doi: 10.1016/j.acuro.2015.09.005

    Mitchell, D. L., Tracy, C. R., Buatti, J. M., Smith, M. C., Snow, A. N., Henry, M. D., et al. (2016). Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions. Clin Genitourin Cancer, 14(1), 12-21. doi: 10.1016/j.clgc.2015.07.022

    Moriceau, G., Guillot, A., Pacaut, C., Mery, B., Falk, A. T., Trone, J. C., et al. (2016). Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer Patients. Chemotherapy, 61(3), 127-133. doi: 10.1159/000441379

    Moschini, M., Sharma, V., Zattoni, F., Quevedo, J. F., Davis, B. J., Kwon, E., et al. (2016). Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy. Eur Urol, 69(1), 135-142. doi: 10.1016/j.eururo.2015.03.036

    Rath, H. M., Ullrich, A., Otto, U., Kerschgens, C., Raida, M., Hagen-Aukamp, C., et al. (2016). Psychosocial and physical outcomes of in- and outpatient rehabilitation in prostate cancer patients treated with radical prostatectomy. Support Care Cancer, 24(6), 2717-2726. doi: 10.1007/s00520-016-3076-7

    Raziee, H., & Berlin, A. (2016). Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life. Front Oncol, 6, 70. doi: 10.3389/fonc.2016.00070

    Ristau, B. T., Cahn, D., Uzzo, R. G., Chapin, B. F., & Smaldone, M. C. (2016). The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer. Future Oncol, 12(5), 687-699. doi: 10.2217/fon.15.355

    Rossi, M. S., Moschini, M., Bianchi, M., Gandaglia, G., Fossati, N., Dell'Oglio, P., et al. (2016). Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? J Sex Med, 13(4), 669-678. doi: 10.1016/j.jsxm.2016.02.160

    Rudman, S. M., Gray, K. P., Batista, J. L., Pitt, M. J., Giovannucci, E. L., Harper, P. G., et al. (2016). Risk of prostate cancer specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence. BJU Int. doi: 10.1111/bju.13428

    Schiller, K. C., Habl, G., & Combs, S. E. (2016). Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer? Front Oncol, 6, 8. doi: 10.3389/fonc.2016.00008

    Sterzing, F., Kratochwil, C., Fiedler, H., Katayama, S., Habl, G., Kopka, K., et al. (2016). (68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients. Eur J Nucl Med Mol Imaging, 43(1), 34-41. doi: 10.1007/s00259-015-3188-1

    Tay, K. J., Moul, J. W., & Armstrong, A. J. (2016). Management of Prostate Cancer in the Elderly. Clin Geriatr Med, 32(1), 113-132. doi: 10.1016/j.cger.2015.08.001

    Tosoian, J. J., Sundi, D., Trock, B. J., Landis, P., Epstein, J. I., Schaeffer, E. M., et al. (2016). Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol, 69(4), 576-581. doi: 10.1016/j.eururo.2015.09.032

    van Stam, M. A., Aaronson, N. K., Pos, F. J., Bosch, J. L., Kieffer, J. M., Tillier, C. N., et al. (2016). The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients. Eur Urol. doi: 10.1016/j.eururo.2016.03.010

    van Velthoven, R., Aoun, F., Marcelis, Q., Albisinni, S., Zanaty, M., Lemort, M., et al. (2016). A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer. Prostate Cancer Prostatic Dis, 19(1), 79-83. doi: 10.1038/pcan.2015.55

    Verzella, D., Fischietti, M., Capece, D., Vecchiotti, D., Del Vecchio, F., Cicciarelli, G., et al. (2016). Targeting the NF-kappaB pathway in prostate cancer: a promising therapeutic approach? Curr Drug Targets, 17(3), 311-320.

    Vignani, F., Bertaglia, V., Buttigliero, C., Tucci, M., Scagliotti, G. V., & Di Maio, M. (2016). Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. Cancer Treat Rev, 44, 61-73. doi: 10.1016/j.ctrv.2016.02.002

    Wallis, C. J., Mahar, A. L., Choo, R., Herschorn, S., Kodama, R. T., Shah, P. S., et al. (2016). Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. BMJ, 352, i851. doi: 10.1136/bmj.i851

    Whiting, P. F., Moore, T. H., Jameson, C. M., Davies, P., Rowlands, M. A., Burke, M. A., et al. (2016). Symptomatic and quality of life outcomes following treatment for clinically localized prostate cancer: a systematic review. BJU Int. doi: 10.1111/bju.13499

    Williams, S. B., Davis, J. W., Wang, X., Achim, M. F., Zurita-Saavedra, A., Matin, S. F., et al. (2016). Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clin Genitourin Cancer, 14(2), 130-138. doi: 10.1016/j.clgc.2015.10.008

    Zelefsky, M. J., Poon, B. Y., Eastham, J., Vickers, A., Pei, X., & Scardino, P. T. (2016). Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. Radiother Oncol, 118(1), 85-91. doi: 10.1016/j.radonc.2015.11.035

22 LINKS TO WEB SITES THAT MAY BE USEFUL IN FINDING INFORMATION, GUIDANCE, AND SUPPORT:

 

[Back to Top]